Bhrigs

Mind Meets Machine: Global

Business EN ↓ 18 episodes

Mind Meets Machine explores the evolving relationship between neurotech, artificial intelligence, human cognition, mental health and leadership. From AI systems and strategy to neurotechnology, brain-computer interfaces, and human augmentation, this podcast examines how intelligent machines are reshaping decision-making, leadership, and the future of work. Through thoughtful conversations and deep dives, we ask: How do we build intelligence that amplifies human potential, not replaces it? For builders, leaders, and thinkers shaping the Intelligence Era.

Be sure to visit the podcast's website and support the creator: podcasters.spotify.com

Author

Bhrigs

Category

Business

Podcast website

podcasters.spotify.com

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Building Clinician Trust in Medical AI: Meraj A. Khan on Explainability, Fairness and Focus 17.11.2026

A valuable conversation with Meraj Khan, co-founder and CEO of DigiBiomics, an AI-enabled medtech company. His lessons apply directly to anyone building in neurotech. 🔹 Keep clinicians central. AI should support the clinician's decision, not replace it. That means outputting a score with a confidence level rather than a yes or no, showing the evidence behind each signal, and using a multimoda...

Precision Psychiatry and the Future of Depression Treatment with Peter Zhukovsky 09.11.2026

Depression rarely looks the same in two people. So why do we still treat it mostly by trial and error? On this episode of Mind Meets Machine: Global, I spoke with Peter Zhukovsky, Assistant Professor and Scientist at CAMH (Centre for Addiction and Mental Health), about how brain imaging, clinical data and AI could help match people to the depression treatments most likely to work for them. A few i...

Building Decision-Grade Evidence for Health Product Success with Bahareh Kardeh 29.10.2026

Many health products look solid on paper and still fall apart in the real world. Often the gap is not the technology. It is the evidence behind the decisions. In this episode, I sat down with @Bahareh Kardeh, founder and principal consultant at BrightPath Consulting, to talk about how health product teams can move from assumptions to confident decisions. Bahareh brings a rare combination to this c...

Keeping the Brain in Balance: Neurons, Noise and Healing Scars with Ankit Roy 23.10.2026

Your neurons are constantly working to stay in balance. When that balance slips, the consequences can be serious. I spoke with neuroscientist Ankit Roy about how the brain keeps its activity in check, and what happens when it doesn't. A few insights that stood out: 🔹 Too little activity and the brain can't convey information properly. Too much and it becomes unstable, as seen in epilepsy....

Sound Meets Signal: Jean Rintoul on Ultrasound Neuromodulation, Open-Source Hardware, and Bridging the Translation Gap 14.10.2026

My latest guest on Mind Meets Machine: Global is @Jean Rintoul, founder of Minds Eye Labs, who has built hardware across multiple biosensor products and is now working on non-invasive ways to sense and stimulate the brain using ultrasound. A few insights that stood out: 🔹 Translation needs its own funding model. Academic grants reward novel findings, and VC funding looks for products. The unglamo...

Signals with Purpose: Reza Khanbabaie on Seizure Prediction, Pharma-Backed Innovation and Patient-Centred Neurotech 13.10.2026

I sat down with Reza Khanbabaie a former founder and CEO with over 20 peer-reviewed papers and four patents, who has spent 25 years turning brain signals into technology for patients. Today he is at Mentis Care AI, building AI to detect and predict seizures for people living with epilepsy. A few insights that stood out: 🔹 Who backs you shapes what you build. Mentis Care AI is pharma-backed rather...

Turning a life altering facial paralysis into a remarkable career in neuroengineering: my conversation with Nilou Hashemi 14.09.2026

This week on Mind Meets Machine: Global, I sat down with Nilou Hashimi, whose path into neuroengineering started with an 11-hour emergency brain surgery. We covered a lot of ground: → How a decade of medical uncertainty, from a facial paralysis to a life-altering surgery, shaped Nilou's decision to pursue rehabilitation engineering and neuroscience → A parallel reflection on navigating health unce...

From XR to EEG: Atif Mahmud on Turning Brainwaves into Actionable Signals 09.09.2026

This week: the gap between reading a brain signal and understanding what it means. I spoke with Atif Mahmood, a computational neuroscience researcher building real time EEG neurofeedback tools for children's emotional regulation, about the hard problems in translating brain data into usable insight. We cover: → Why brain activity readings can be misleading without context → How gaming architecture...

Biotech At The Crossroads: Trade, War & the Future of Medical Innovation 14.08.2026

While GLP-1 drugs and established medtech pulled in billions and shrugged off tariffs, early-stage biotech funding hit a five-year low and neurotech startups were left fighting for scraps. → Political leverage is now a balance sheet asset. Novo Nordisk and Eli Lilly negotiated directly with the White House and walked away with three years of tariff relief. That's not luck. That's strategic...

10 NeuroTech Use Cases That Could Put You Ahead of Your Own Mind 06.08.2026

What if a headset could tell you an anxiety attack was coming, moments before you felt it? That's not ten years out. In this episode of Mind Meets Machine: Global, I go through 10 potential and real use cases for non-invasive brain-computer interfaces: anxiety, addiction, trauma therapy, ADHD, insomnia, loneliness, even early psychosis detection. And then I paint a highly detailed scenario and...

Don't Get Left Behind – Again: Preparing for the Age of BCIs 20.07.2026

We all said the same thing about AI: "I'll pay attention when it matters." By the time it mattered, we were already playing catch-up. I don't want us to make that mistake twice. The next technological wave is already here. Not in science fiction, but in operating rooms, research labs, and clinical trials around the world. While most of us are debating AI, another revolution is qu...

Wired for Power: The Neuralink Governance Problem 16.07.2026

The most consequential technologies are rarely undone by bad science. They're undone by bad governance. Case in point: a regulator who oversaw Neuralink's brain implant now works at Neuralink. The FDA's own device chief the man whose office reviewed the company's file walked straight into a job there in December 2025. Legal? Yes. But it's a clean window into what happens when h...

(Part 2) The Neural Implant & BCI Industry Landscape 06.07.2026

In this episode we analyze the Industry Landscape of BCI Implants. The section closes with a strategic framework for how to think about market sizing, investment, and what it actually takes to build a durable business in one of the most capital-intensive and regulatory-complex sectors in all of technology. Key Topics: The Industry Overview The Technology Landscape The Major Players - Top Three Ope...

(Part 1) The Neural Implant & BCI Industry Landscape 01.07.2026

In this episode we analyze the Industry Landscape of healthcare Neural Implants and go over: The Industry Overview The Technology Landscape The Major Players - Top Three Operational Realities Competitive Dynamics & How to Win Building an Ecosystem The Global Picture ------------------------------------------------------------- Additional Notes and References:        For current up-to-date figu...

From the Operating Room to the Algorithm: The Future of Treating Depression and Anxiety 28.06.2026

The Neurotechnology of Mental Health. Anxiety and depression usually get framed as emotional experiences. This episode argues they're also disorders of brain circuitry, and that reframing opens the door to treating them with medical technology, not just therapy and medication. We walk through the full spectrum. Invasive options like Deep Brain Stimulation and Vagus Nerve Stimulation, reserved...

Centralized or Distributed? The Real AI Org Design Decision 22.06.2026

Centralized or Distributed? The Real AI Org Design Decision Every growing organization eventually faces the same question: should AI capability live in one central team, or spread across the business units that need it? In this episode, we walk through how that decision actually plays out as companies scale, and why the "right" answer shifts the moment headcount and complexity grow. We c...

The Middle-Management AI Crisis: Who Gets to Lead, Who Gets Left Behind 19.06.2026

Middle managers have quietly become one of the most anxious groups in today's workplace, and this episode tackles why head-on. The host opens with a direct question: is AI actually eliminating middle management, or is it exposing a structural problem organizations have ignored for decades? The episode traces the role's history, from pre-1990s information pipelines, through the IT revolutio...

Your Brain is Changing With or Without You: The Convergence of Neurotech, Brain-Computer Interfaces, AI, Psychedelics, and Mental Health 18.06.2026

What happens when psychedelics, neurotechnology, AI, brain-computer interfaces, and even ancient healing practices like Reiki begin converging into a single ecosystem? In this thought-provoking episode, we explore how neuroscience and artificial intelligence are reshaping our understanding of the human brain and what that means for mental health, healing, performance, and the future of human poten...

Listen to the Mind Meets Machine: Global podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.